Despite Patient Deaths Associated with Actemra, Drugmaker Genentech Continues to Seek Approval for Additional Indications June 19, 2024 …Genentech and its corporate parent, Roche, makers of the rheumatoid arthritis medication Actemra, are already facing litigation over hundreds of deaths linked to the product. Nonetheless, they have been busy exploring new purposes… Read More
Bill Cash March 29, 2024 …proceedings at the Judicial Panel on Multidistrict Litigation. Before transitioning to class action work, Cash led the charge in several drug products liability mass torts, including cases against Merck, Roche… Read More
Syngenta spent decades attempting to quiet health concerns about its profitable herbicide. November 7, 2024 …the research of Deborah Cory-Slechta, a researcher at the University of Rochester in New York. In the early 2000s, Cory-Slechta’s studies found that administering paraquat to mice caused cell death… Read More
Levin Law
Levin Law